Chelation therapy and atherosclerotic coronary artery disease

Canadian Coordinating Office for Health Technology Assessment
Record ID 31995000009
English, French
Authors' objectives:

Review the use of chelation for treating heart disease; requested by provincial governments.

Authors' results and conclusions: a) There is no scientifically acceptable evidence that chelation therapy is effective in treating heart disease, preventing repeat MI or death. Studies to date have been poorly designed, and are anecdotal, case studies or patient series; b) Safety has not been clearly established; c) It has yet to be shown that the costs of chelation are worth the benefits that are attributed to it.
Authors' methods: Review
Details
Project Status: Completed
URL for project: https://www.ccohta.ca/
Year Published: 1993
English language abstract: An English language summary is available
Publication Type: Not Assigned
Country: Canada
MeSH Terms
  • Arteriosclerosis
  • Edetic Acid
  • Chelation Therapy
Contact
Organisation Name: Canadian Coordinating Office for Health Technology Assessment
Contact Address: 600-865 Carling Avenue, Ottawa, ON K1S 5S8 Canada. Tel: +1 613 226 2553, Fax: +1 613 226 5392;
Contact Name: jills@ccohta.ca
Contact Email: jills@ccohta.ca
Copyright: Canadian Coordinating Office for Health Technology Assessment
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.